Papers - TAIMA KAGEAKI
-
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.
Hisashi Tanaka, Kageaki Taima, Tomonori Makiguchi, Junichi Nakagawa, Takenori Niioka, Sadatomo Tasaka
Cancer communications (London, England) 41 ( 1 ) 83 - 87 2021.1
-
The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study.
Masaki Dobashi, Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka, Toshihiro Shiratori, Fumihiko Okumura, Chiori Tabe, Yoshihito Tanaka, Takeshi Morimoto, Yukihiro Hasegawa, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
SAGE open medicine 9 20503121211023357 - 20503121211023357 2021
-
A Phase I/II study of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer.
Tanaka H, Hasegawa Y, Makiguchi T, Okumura F, Tabe C, Shiratori T, Ishioka Y, Itoga M, Taima K, Yokouchi J, Hatayama Y, Aoki M, Tasaka S.
Clin Lung Cancer 22(1) 42 - 48 2021
-
A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non-small-cell Lung Cancer.
Hisashi Tanaka, Yukihiro Hasegawa, Tomonori Makiguchi, Fumihiko Okumura, Chiori Tabe, Toshihiro Shiratori, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Junichi Yokouchi, Yoshiomi Hatayama, Masahiko Aoki, Sadatomo Tasaka
Clinical lung cancer 22 ( 1 ) 42 - 48 2020.10
-
Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review.
Toshihiro Shiratori, Hisashi Tanaka, Chiori Tabe, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Shingo Takanashi, Sadatomo Tasaka
Thoracic cancer 11 ( 6 ) 1720 - 1723 2020.6
-
Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review.
Shiratori T, Tanaka H, Tabe C, Tsuchiya J, Ishioka Y, Itoga M, Taima K, Takanashi S, Tasaka S
Thoracic cancer 11 ( 6 ) 1720 - 1723 2020.6
-
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab.
Kageaki Taima, Hisashi Tanaka, Masamichi Itoga, Yoshiko Ishioka, Akira Kurose, Sadatomo Tasaka
Respirology case reports 8 ( 5 ) e00580 - e00580 2020.5
-
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer
Tanaka H, Tabe C, Okumura F, Shiratori T, Ishioka Y, Itoga M, Taima K, Morimoto T, Kimura D, Tsushima T, Tasaka S.
Thorac Cancer 11 1633 - 1638 2020.4
-
繰り返す血胸・気胸を契機に診断された血管型Ehlers-Danlos症候群
石岡佳子，白鳥俊博，當麻景章，糸賀正道，林 周次郎，田坂定智
日呼吸誌 9 ( 6 ) 473 - 476 2020
-
The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations.
Hiroaki Sakamoto, Hisashi Tanaka, Toshihiro Shiratori, Keisuke Baba, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Yukihiro Hasegawa, Shingo Takanashi, Sadatomo Tasaka
Molecular and clinical oncology 10 ( 6 ) 610 - 614 2019.6
-
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer.
Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka, Keisuke Baba, Toshihiro Shiratori, Hiroaki Sakamoto, Junichiro Tsuchiya, Hideyuki Nakagawa, Yukihiro Hasegawa, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Medical oncology (Northwood, London, England) 36 ( 6 ) 57 - 57 2019.5
-
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer.
Tanaka H, Taima K, Itoga M, Ishioka Y, Baba K, Shiratori T, Sakamoto H, Tsuchiya J, Nakagawa H, Hasegawa Y, Yasugahira H, Okudera K, Takanashi S, Tasaka S
Medical oncology (Northwood, London, England) 36 ( 6 ) 57 2019.5
-
Efficacy of pembrolizumab for patients with both high PD-L1 expression and an MET exon 14 skipping mutation: A case report.
Keisuke Baba, Hisashi Tanaka, Hiroaki Sakamoto, Toshihiro Shiratori, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Sadatomo Tasaka
Thoracic cancer 10 ( 2 ) 369 - 372 2019.2
-
A Case of Large Cell Neuroendocrine Carcinoma Successfully Treated with Nivolumab
Tabe Chiori, Tanaka Hisashi, Taima Kageaki, Itoga Masamichi, Shiratori Toshihiro, Tasaka Sadatomo
Haigan 59 ( 7 ) 1156 - 1161 2019
-
Emergency Radiotherapy for Spinal Cord Compression due to Bone Sarcoidosis.
Yoshihito Tanaka, Kageaki Taima, Hisashi Tanaka, Masamichi Itoga, Yoshiko Ishioka, Toshihiro Shiratori, Junichiro Tsuchiya, Hiroaki Sakamoto, Shingo Takanashi, Sadatomo Tasaka
Internal medicine (Tokyo, Japan) 57 ( 5 ) 717 - 720 2018.3
-
A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutations.
Hisashi Tanaka, Kageaki Taima, Yoshihito Tanaka, Masamichi Itoga, Yoshiko Ishioka, Hideyuki Nakagawa, Keisuke Baba, Yukihiro Hasegawa, Shingo Takanashi, Sadatomo Tasaka
Medical oncology (Northwood, London, England) 35 ( 3 ) 34 - 34 2018.2
-
A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer.
Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, Yoshihito Tanaka, Masamichi Itoga, Kunihiko Nakamura, Akihito Hayashi, Mika Kumagai, Hideo Yasugahira, Megumi Mikuniya, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
BMC cancer 17 ( 1 ) 683 - 683 2017.10
-
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials.
Toshiyuki Harada, Toraji Amano, Tomoo Ikari, Kei Takamura, Takahiro Ogi, Toshiaki Fujikane, Yuka Fujita, Kageaki Taima, Hisashi Tanaka, Takaaki Sasaki, Shunsuke Okumura, Shunichi Sugawara, Hiroshi Yokouchi, Noriyuki Yamada, Naoto Morikawa, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura
Frontiers in pharmacology 8 972 - 972 2017
-
Regression of Crizotinib-Associated Complex Cystic Lesions after Switching to Alectinib
Taima Kageaki, Tanaka Hisashi, Tanaka Yoshihito, Itoga Masamichi, Takanashi Shingo, Tasaka Sadatomo
Internal Medicine 56 ( 17 ) 2321 - 2324 2017
-
Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status.
Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, Kunihiko Nakamura, Yoshihito Tanaka, Masamichi Itoga, Shingo Takanashi, Ken Okumura
BMC research notes 9 ( 1 ) 173 - 173 2016